Kent Laboratories, Inc. – FDA 483, Jul 28, 2026

Kent Laboratories, Inc. in Bellingham, WA, received a Form 483 with two observations during an FDA inspection. The firm failed to adequately document both corrective action and preventive action procedures, indicating significant deficiencies in its quality system. These issues suggest a moderate level of non-compliance with regulatory requirements for medical device manufacturers.